Page last updated: 2024-08-21

benzoxazoles and Urinary Bladder Neoplasms

benzoxazoles has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ando, K; Anzai, N; Furihata, T; Higuchi, K; Ichikawa, T; Ikehara, Y; Imamura, Y; Kanai, Y; Kaneda, A; Kyprianou, N; Maimaiti, M; Nakamura, K; Rii, J; Sakamoto, S; Sazuka, T; Sugiura, M; Takeuchi, N; Xu, M; Yamada, Y	1

Other Studies

1 other study(ies) available for benzoxazoles and Urinary Bladder Neoplasms

Article	Year
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma. Scientific reports, 2020, Jan-28, Volume: 10, Issue:1 Topics: Benzoxazoles; Cell Line, Tumor; Disease-Free Survival; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Male; MAP Kinase Signaling System; Neoplasm Proteins; Survival Rate; TOR Serine-Threonine Kinases; Tyrosine; Urinary Bladder Neoplasms	2020

Article

Year

Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.

Scientific reports, 2020, Jan-28, Volume: 10, Issue:1

Topics: Benzoxazoles; Cell Line, Tumor; Disease-Free Survival; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Male; MAP Kinase Signaling System; Neoplasm Proteins; Survival Rate; TOR Serine-Threonine Kinases; Tyrosine; Urinary Bladder Neoplasms

2020